Atea Pharmaceuticals Inc (AVIR)

NASDAQ
8.38
-0.18(-2.10%)
After Hours
8.50
+0.12(+1.43%)
- Real-time Data
  • Volume:
    238,507
  • Day's Range:
    8.28 - 8.56
  • 52 wk Range:
    5.31 - 46.91

AVIR Overview

Prev. Close
8.56
Day's Range
8.28-8.56
Revenue
224.99M
Open
8.56
52 wk Range
5.31-46.91
EPS
0.187
Volume
238,507
Market Cap
697.71M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
597,824
P/E Ratio
46.49
Beta
0.566
1-Year Change
-71.31%
Shares Outstanding
83,258,603
Next Earnings Date
Nov 10, 2022
What is your sentiment on Atea?
or
Market is currently closed. Voting is open during market hours.

Atea Pharmaceuticals Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Atea Pharmaceuticals Inc Company Profile

Atea Pharmaceuticals Inc Company Profile

Employees
56

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, a novel antiviral agent that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 that is in Phase I/IIa clinical trial for the treatment of chronic hepatitis C; and AT-889, an investigational, second-generation nucleoside pyrimidine prodrug and other compounds for the treatment of respiratory syncytial virus. It has a Roche License Agreement with F. Hoffmann-La Roche Ltd and Genentech, Inc. for development and commercialization related to AT-527 outside of the United States. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuySellSellBuySell
Technical IndicatorsSellStrong BuyStrong SellBuyStrong Sell
SummaryNeutralNeutralStrong SellBuyStrong Sell
  • whos following this garbage?
    0
    • It seems to me that there will be a short sqeeze here soon, I bought it for $ 6.77
      0
      • Avir must pump
        0
        • 🚀🚀🚀
          0
          • ???
            0
        • any comment ?
          0
          • AVIR (P) 0.00000000 42.98000000
            0
            • What is premkt volume?
              0
              • @ 14.01, 26 pt drop..why? what's the bad news. I feel like it's going up AMarket.
                0
                • this is my business and from this i live.!
                  2
                • what do you think about avir ?
                  0
                • i know what will happen to Avir but i have to receive payment about this as i am expert and i am living from this. if you are willing to pay some fees i can give you my report for Avir and Prediction.
                  2
              • ?
                0
                • anybody around? What are yor feelings? Cheers.
                  0